Peeters, Lukas
Hoen, Mick
Hofman, Delian
Hompes, Bjorn
Langenveld, Bart
Smeets, Danae
Lenderink, Timo
Brunner-La Rocca, Hans Peter
Sanders-van Wijk, Sandra
Article History
Received: 21 February 2025
Accepted: 5 November 2025
First Online: 5 January 2026
Conflict of interest
: H.P. Brunner-La Rocca received speaker/consulting fees from Novartis, AstraZeneca, Boehringer Ingelheim, Roche diagnostics and Novo Nordisk and unrestricted research grants from Novartis and Roche diagnostics. S. Sanders-van Wijk received speaker/consulting fees from Novartis, Bayer, Astra Zeneca, Boehringer Ingelheim, Pfizer, Roche diagnostics and Novo Nordisk and grant support from Astra Zeneca and the CRL fund (Cardiologie research Limburg). L. Peeters, M. Hoen, D. Hofman, B. Hompes, B. Langenveld, D. Smeets and T. Lenderink declare that they have no competing interests.